Camden National director granted 919 CAC shares

Merrill Robert D reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Merrill Robert D reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp director Robert D. Merrill received a stock grant of 919 shares of Common Stock as compensation. The shares were granted under the Independent Directors' Equity Compensation Program, which is part of the 2022 Equity and Incentive Plan and its amendment.

The grant carried no purchase price and vested immediately on the grant date, meaning Merrill gained full ownership right away. Following this award, his direct holdings increased to 11,423.8065 shares of Camden National Corp common stock, reflecting a routine, compensation-related equity increase rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 919 shares

Grant/Award 1 txn

Insider Merrill Robert D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	919	$0.00	$0.00

Holdings After Transaction: Common Stock — 11,423.8065 shares (Direct)

Footnotes (1)

1. F1. Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A. These shares vested immediately on the date of the grant.

Key Figures

Shares granted: 919 shares Price per share: $0.00 per share Holdings after grant: 11,423.8065 shares +1 more

4 metrics

Shares granted 919 shares Director equity grant of Common Stock

Price per share $0.00 per share Equity compensation grant, not market purchase

Holdings after grant 11,423.8065 shares Total direct Common Stock held by Robert D. Merrill

Transaction code A Grant, award, or other acquisition of Common Stock

Key Terms

Independent Directors' Equity Compensation Program, 2022 Equity and Incentive Plan, vested immediately

3 terms

Independent Directors' Equity Compensation Program financial

"Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan"

2022 Equity and Incentive Plan financial

"a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A"

vested immediately financial

"These shares vested immediately on the date of the grant"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Camden National (CAC) director Robert D. Merrill report in this Form 4?

Robert D. Merrill reported receiving a grant of 919 shares of Camden National common stock. The award was issued as director compensation under the company’s equity plan, with no cash paid and immediate vesting on the grant date, increasing his direct holdings.

How many Camden National (CAC) shares did Robert D. Merrill receive in the latest grant?

He received 919 shares of Camden National common stock. This award came through the Independent Directors' Equity Compensation Program as part of the 2022 Equity and Incentive Plan, representing a routine director compensation grant rather than an open-market stock purchase.

What are Robert D. Merrill’s Camden National (CAC) holdings after this Form 4 transaction?

After the grant, Merrill directly owns 11,423.8065 shares of Camden National common stock. This total reflects the addition of 919 immediately vested shares awarded as part of the company’s equity-based compensation for independent directors under its 2022 plan.

Did Robert D. Merrill pay a price per share for the new Camden National (CAC) stock?

No, the reported price per share for the 919-share grant is zero dollars. The filing explains this is because the shares were granted as equity compensation to an independent director, not bought in the market, and they vested immediately upon grant.

Under which program was the Camden National (CAC) stock grant to Robert D. Merrill made?

The 919-share grant was made under the Independent Directors' Equity Compensation Program. This program is a component of Camden National’s 2022 Equity and Incentive Plan and its amendment, providing stock-based compensation to independent board members instead of cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Merrill Robert D

(Last) (First) (Middle)

2 ELM STREET

P.O. BOX 310

(Street)

CAMDEN MAINE 04843

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		A		919	A	$0(1)	11,423.8065	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A. These shares vested immediately on the date of the grant.

Remarks:

	Christopher G. Hutchinson, POA	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)